Search results for "LETTER TO THE EDITOR."

Letter to the Editor: Comment on “The Application of Artificial Intelligence for the Diagnosis and Treatment of Liver Diseases”

2021

among the forthcoming articles to be published in Hepatology, I noticed the extensive review by Ahn, Connell, Simonetto, Hughes & Shah concerning "The application of artificial intelligence for the diagnosis and treatment of liver diseases" [1]. As a bioethicist, I need to raise some concern about the perspective given by this review, which disregards some important issues concerning ethical aspects and patient-physician relationship.

Comment on the Letter to the Editor by Professor Reiber

2009

Letter to the Editor. From a polemic paradox to a proper perspective of job burnout and job satisfaction.

2019

In Reply to the Letter to the Editor: “Comparing the Volume of Brain Metastases in F-18-FET-PET and MRI”

2016

Letter to the Editor Regarding “First Report of Extraspinal Lead Migration Along a Thoracic Spinal Nerve After Spinal Cord Stimulation”

2021

Letters to the Editor : Stratégies d’utilisation par une communauté de chercheurs francophones et tentative de caractérisation du genre

2002

Cet article se fixe comme objectif d’analyser la fonction et l’utilisation du genre Letters to the Editor au sein d’une communauté de chercheurs francophones. L’impact et la représentation de ce mode d’expression scientifique ont été mesurés à l’aide d’une enquête sous forme de questionnaire dont les résultats sont rapportés et analysés. Cette étude permet de dégager les stratégies d’utilisation du genre et conduit à proposer quelques pistes pouvant aboutir à la caractérisation du genre. Ce travail s’appuie également sur l’analyse comparée d’un corpus (1999-2001) composé à partir d’une revue de biologie et d’une revue médicale. The aim of this paper is to analyse the goal, role and use of t…

Quelques aspects de la contradiction et de la remise en cause dans le genre Letters to the editor

2001

Cette communication se fixe comme objectif de repérer quelques stratégies discursives de deux communautés de chercheurs et de comparer leur matérialisation linguistique dans un corpus de Letters to the Editor composé à partir de deux revues : The American Journal of Clinical Nutrition et de The Lancet. La stratégie de remise en cause est analysée comme le mode explicite ou implicite de la contradiction apportée à un fait scientifique établi. Ce discours, identifié comme un genre, se situe dans la logique de véridiction du discours scientifique. The aim of this study is to pick out a few discursive strategies in two research communities and to perform a comparative analysis of their linguist…

Reply to the letter to the editor ‘How much evidence isn't in evidence-based guidelines?’ by Johnson et al.

2015

ABSTRACT ESMO produces pan-European, multidisciplinary, peer-reviewed and updatable guidelines with global impact on current clinical practice, with the intention of providing the practising health professional in cancer care with an easy to use, evidence-based tool for optimal patient management. Levels of evidence and strength of recommendation metrics are provided. In the Dyspnoea ESMO CPG, we strove to fulfill these targets, though we accept any productive criticism that will contribute to the improvement of the product.

Pyridoxine dependent epilepsies: new therapeutical point of view

2017

Abstract Pyridoxine dependent epilepsies (PDEs) are rare autosomal recessive disorders with onset in neonatal period. Seizures are typically not responsive to conventional antiepileptic drugs, but they cease after parental pyridoxine administration. Atypical forms are characterized partly response to pyridoxine and a late onset of symptoms (up to the age of three years). Prevalence is variable and it has rarely been described. The genes involved in PDEs are the gene encoding for the Alpha-aminoadipic-semialdehyde dehydrogenase (ALDH7A1) and PROSC gene, which encodes a pyridoxal-5-phosphate binding protein. Mutations in the gene encoding for the pyridoxal-5′-phosphate oxidase enzyme (PNPO) a…

Clinical and demographic characteristics of patients dying from COVID-19 in Italy vs China.

2020

Abstract Coronavirus disease 2019 (COVID‐19), an infectious outbreak caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2),1 has now progressed to global pandemic.2 Besides the compelling need to understand the novel biological pathways underlying the virulence and pathogenicity of SARS‐CoV‐2 in humans to enable the development of appropriate interventions and therapies,3,4 the noticeable difference in mortality rates between Asian and European populations is one of the most significant issues demanding the attention of biologists, epidemiologists and clinicians around the world. This article is protected by copyright. All rights reserved.